Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:42:19.704Z.
Calculation as of: 2026-10-06T19:42:19.704Z.
Quote observation: 2026-10-06T19:40:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 564e985820cc4d82a577ec1dab8a2942c5d07d58deba224fe20754c365e89b20
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$76.24M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.45M
EV/EBITDA Ratio
10.34x
TTM Avg
27.31x
3Y Avg
27.31x
5Y Avg
27.31x
Market Cap
$72.83M
EV/EBITDA Ratio
N/A
TTM Avg
161.81x
3Y Avg
161.81x
5Y Avg
161.81x
Market Cap
$78.07M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmonx Corporation (LUNG) | $75.06M | N/A | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $73.81M | N/A | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $76.24M | N/A | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $76.45M | 10.34x | 27.31x | 27.31x | 27.31x |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.06M | N/A | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $76.56M | N/A | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | N/A | 161.81x | 161.81x | 161.81x |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | N/A | N/A | N/A | N/A |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $71.64M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
